03 Profile
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Diabetes
Ania Jastreboff
Professor, lead investigator on the retatrutide trial at Yale School of Medicine
press citations on 1 topic since 22 May 2026 · last quoted 21 Aug 2026
02 Quoted on · 1 of 29 topics
Ania Jastreboff: key facts
- Kind of voice
- Academic
- Role
- Professor, lead investigator on the retatrutide trial at Yale School of Medicine
- Quoted on
- Diabetes
- Tracked press citations
- 6
- Most recently quoted
- 21 Aug 2026
- First quoted
- 22 May 2026
04 The signal · where Ania Jastreboff sits on diabetes
Ranked 17= of 100 voices quoted in the press on diabetes, level with 5 others on 6 citations.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1
Douglas TwenefourClinicianHead of Clinical, Diabetes UK36 - 2
Dr Elizabeth RobertsonSector leaderDirector of Research and Clinical, Diabetes UK20 - 3=
Helen KnightRegulatorDirector of Medicines Evaluation, National Institute for Health and Care Excellence (NICE)15 - 17=
Dr Sonya Babu-NarayanClinicianClinical Director, British Heart Foundation6 - 17=Professor Partha KarClinicianConsultant in Diabetes and Endocrinology at Portsmouth Hospitals NHS Trust6
- 17=Ania JastreboffAcademicProfessor, lead investigator on the retatrutide trial at Yale School of Medicine6
- 17=Rebecca ReynoldsAcademicProfessor, University of Edinburgh6
- 17=Helen KirraneSector leaderHead of policy, campaigns and mobilization at Diabetes UK6
Showing the leaders and the ranks around 17=, of 100 voices · See every voice on the topic →
05 On the record · press
What Ania Jastreboff has said
- ladbible.com5
- technologynetworks.com1
Where Ania Jastreboff has been quoted
- 01'Unbearable' side effect of 'world's most powerful weight loss drug' revealed by usersladbible.com · 21 Aug 2026
- 02'Reta' manufacturers issue warning over weight loss drug as online sellers expose legal loopholeladbible.com · 30 Jun 2026
- 03Doctor issues serious warning over 'most powerful' weight-loss jab as fears it's becoming 'new steroids' growladbible.com · 29 Jun 2026
- 04Overweight Patients Lose Nearly 30% Body Weight in Phase 3 Retatrutide Trialtechnologynetworks.com · 10 Jun 2026
- 05'Most powerful weight-loss jab ever' that outperforms Wegovy and Mounjaro shows insane resultsladbible.com · 22 May 2026
- 06Doctor issues serious warning over 'most powerful weight loss jab ever' that outperforms Mounjaro and WeGovyladbible.com · 22 May 2026
Verbatim
“It was impressive to see that every dose of retatrutide resulted in clinically meaningful weight reduction for nearly all participants, and people with severe obesity on the highest dose lost on average 30 percent of their body weight over two years”
“It was impressive to see that every dose of retatrutide resulted in clinically meaningful weight reduction for nearly all participants, and people with severe obesity on the highest dose lost on average 30 percent of their body weight over two years.”
“For patients I see in clinic, retatrutide may potentially be a highly impactful future tool to treat their obesity and transform their health trajectory.”
“Obesity drives more than 200 downstream diseases, yet we have historically treated those conditions one at a time and in silos”
“For patients I see in clinic, retatrutide may potentially be a highly impactful future tool to treat their obesity and transform their health trajectory.”
“For patients I see in clinic, retatrutide may potentially be a highly impactful future tool to treat their obesity and transform their health trajectory.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 13 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.